Patent · US Active

Compounds for use in treating neuromuscular disorders

US10934244B2 · kind B2 · utility

3Cited by
9References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2016
Grant dateMar 2, 2021
Priority date
Expiry dateJun 15, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising compounds for use in treating, ameliorating and/or preventing neuromuscular disorders. The compounds as defined herein preferably inhibit the ClC-1 ion channel. The invention further relates to methods of treating, preventing and/or ameliorating neuromuscular disorders, by administering said composition to a person in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.